Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRQIH.L Regulatory News (RQIH)

  • There is currently no data for RQIH

Q2 Program Management Update

17 Aug 2020 07:00

RNS Number : 2531W
Randall & Quilter Inv Hldgs Ltd
17 August 2020
 

 

 

Randall & Quilter Investment Holdings Ltd.

 

Q2 Program Management Update

 

17 August 2020

 

Randall & Quilter Investment Holdings Ltd. (AIM-RQIH) ("R&Q"), the leading non-life global specialty insurance company focusing on Program Management and Legacy Insurance businesses, announces a performance update for its Program Management business, for the six months ended 30 June 2020.

 

Highlights

 

· Contracted Premium of $924.5 million (H1 2019: $431.6 million), a 114% increase

 

· Gross Written Premium of $247.2 million (H1 2019: $172.9 million), a 43% increase

 

· Economic Commission Revenue1 of $10.7 million (H1 2019: $5.7 million), an 88% increase

 

· Addition of 10 new programs bringing the total number of active programs to 36 (H1 2019: 26)

 

· Subsequent to the end of Q2 2020, four new programs were signed with Contracted Premium of approximately $200 million, all of which are expected to begin generating Gross Written Premium shortly

 

· Expected to enter the US Excess & Surplus ("E&S") Program Management market in Q4 2020

 

Commenting on the Program Management results, Alan Quilter, Group Chief Executive Officer, said:

 

"In the first half of 2020, our Program Management business, trading under the Accredited banner, continued to grow strongly. Importantly, this business has significant built-in growth through the 36 existing programs and 34 different distribution partners with whom we have secured contracts as of the end of Q2 2020. In addition, the four new programs we signed post the half year, are expected to generate in excess of $200 million of annual recurring Gross Written Premium when they achieve scale over the next 18 months.

 

We continue to see strong demand from new origination partners as existing insurance capacity faces capital challenges given the magnitude of the insured losses from Covid 19. Moreover, due to current market conditions, we expect to enter the US E&S Program Management market, a large addressable market in which we do not presently compete, in Q4 2020, accelerating our original plans. This launch will see Accredited achieve its strategic objective of being a comprehensive program management solutions provider in all its major markets."

 

R&Q will provide a further update on its Program Management business for the nine months ended 30 September 2020 in the fourth quarter.

 

1: Economic Commission Revenue represents the Commission Revenue from insurance policies already bound (written), regardless of the length of the underlying policy period (earned). We believe Economic Commission Revenue is a more appropriate measure of the revenue of the business during periods of high growth, due to larger than normal gap between Gross Written and Gross Earned (IFRS) Premium, and the corresponding fees.

 

 

Ends

Notes to Editors:

 

Randall & Quilter Investment Holdings Ltd.

 

Ken Randall

William Spiegel

 

Tel: +44 (0)7831 145440

Tel: +001 917 826 5877

Numis Securities Limited (Nominated Adviser)

Stuart Skinner / Huw Jeremy

Tel: 020 7260 1000

Charles Farquhar

Tel: 020 7260 1000

 

Shore Capital Stockbrokers Limited

Stephane Auton

James Thomas

Tel: 020 7408 4090

 

FTI Consulting

Edward Berry

Tom Blackwell

 

 

Tel: 020 3727 1046

 

About Accredited

 

Accredited is R&Q's Program Management business. Operating in the US, UK and Europe, Accredited is the only program carrier that has an AM Best A- credit rating in all these markets. In the US Accredited is licensed in all 50 states and in the UK/Europe it is licensed to write all classes of non-life business.

 

Accredited has also established a fully authorised UK branch to facilitate continued access to the large UK market, post Brexit. This branch will get the full benefit of Accredited Malta's A- rating from AM Best.

 

Accredited's (US) Financial Strength Category increased in 2019 to an AM Best category IX making it one of the highest rated program managers in the US and providing an important support for the business' continued growth.

 

About R&Q

 

R&Q is a non-life global specialty insurance company operating two core, highly complementary, businesses: Program Management and Legacy Insurance. Both these businesses are leaders in markets with high barriers to entry and significant secular growth opportunities.

 

Legacy Insurance generates profits and capital extractions from expert management of legacy non-life insurance portfolios. Program Management generates commission income from its licensed (and rated) carriers in the US, EU and the UK, writing niche and profitable program business, largely on behalf of highly rated reinsurers.

 

For the financial year ended 31 December 2019 R&Q reported pre-tax profits of over £40 million.

 

Legal Entity Identifier (LEI): 2138006K1U38QCGLFC94

 

Website : www.rqih.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDPFMLTMTJBBLM
Date   Source Headline
22nd Jun 201112:38 pmRNSResult of AGM
22nd Jun 20117:00 amRNSAGM Statement
13th Jun 20113:52 pmRNSNOTIFICATION OF MAJOR INTEREST IN SHARES
27th May 20114:16 pmRNSNotice of AGM
25th May 20115:12 pmRNSCREST Entitlement Credited
16th May 20113:31 pmRNSCREST Entitlement Credited
13th May 20117:00 amRNSSuccessful Outcome of Legal Dispute
12th May 201112:48 pmRNSNotification of Major Interest in Shares
28th Apr 20117:00 amRNSFinal Results
27th Apr 20114:38 pmRNSResult of Meeting
8th Apr 201111:04 amRNSNotification of Major Interest in Shares
5th Apr 201111:17 amRNSNotice of Results
7th Mar 20115:37 pmRNSNotification of Major Interest in Shares
1st Mar 20113:09 pmRNSExercise of Options
24th Feb 20112:05 pmRNSNotification of Major Interest In Shares
16th Feb 20113:18 pmRNSNotification of Major Interest in Shares
16th Feb 20111:29 pmRNSNotification of Major Interest In Shares
15th Feb 201112:30 pmRNSNotification of Major Interest in Shares
14th Feb 20115:38 pmRNSNotification of Major Interest In Shares
12th Jan 201112:55 pmRNSDirector Appointment
7th Dec 201012:27 pmRNSIssue of Equity
10th Nov 20107:00 amRNSApproval of two Managing General Agents (MGAs)
8th Nov 20107:00 amRNSApproval of new syndicate on turnkey basis
1st Nov 20107:00 amRNSCompletion of acquisition
24th Sep 20105:25 pmRNSHolding(s) in Company
16th Sep 20104:53 pmRNSHolding(s) in Company
15th Sep 201011:04 amRNSDirector/PDMR Shareholding
13th Sep 20107:00 amRNSAcquisition of RSL businesses and ETMC.
6th Sep 20101:20 pmRNSHolding(s) in Company
3rd Sep 201012:06 pmRNSResult of General Meeting
20th Aug 20104:20 pmRNSDirector/PDMR Shareholding
19th Aug 20102:20 pmRNSDirector/PDMR Shareholding
18th Aug 20107:00 amRNSReturn of Cash and Share Capital Consolidation
18th Aug 20107:00 amRNSHalf Yearly Report
9th Aug 20107:00 amRNSTrading Statement
30th Jul 20104:53 pmRNSNotification of Major Interest in Shares
30th Jul 20108:51 amRNSNotification of Major Interest in Shares
1st Jul 20109:17 amRNSNotice of Results
23rd Jun 201012:18 pmRNSAGM Statement
16th Jun 20109:43 amRNSNotice of AGM
8th Jun 20101:31 pmRNSChanges to the register of director information
29th Apr 20107:00 amRNSFinal Results
28th Apr 20101:12 pmRNSAppointment of Nominated Advisor and Joint Broker
23rd Apr 20107:00 amRNSAcquisition
22nd Mar 20107:00 amRNSTrading Update
25th Feb 201012:16 pmRNSInterim Dividend
18th Feb 20107:00 amRNSChange of Adviser Name
10th Feb 20107:14 amRNSNotice of Results
10th Feb 20107:10 amRNSChange of Adviser
29th Jan 20107:00 amRNSAgreement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.